Integral Ad Science Holding Corp. (NASDAQ:IAS) Receives Average Recommendation of “Buy” from Brokerages

Shares of Integral Ad Science Holding Corp. (NASDAQ:IASGet Rating) have received a consensus rating of “Buy” from the nine ratings firms that are covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $24.67.

Several equities research analysts have weighed in on IAS shares. Oppenheimer cut their price target on Integral Ad Science from $24.00 to $19.00 in a report on Thursday, May 12th. Stifel Nicolaus upped their target price on shares of Integral Ad Science from $25.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, March 4th. Barclays decreased their price target on shares of Integral Ad Science from $17.00 to $12.00 in a research note on Thursday, May 12th. Finally, Raymond James upgraded shares of Integral Ad Science from an “outperform” rating to a “strong-buy” rating and raised their price objective for the company from $26.00 to $27.00 in a report on Monday, March 21st.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Ameritas Investment Partners Inc. lifted its stake in Integral Ad Science by 92.1% in the first quarter. Ameritas Investment Partners Inc. now owns 2,499 shares of the company’s stock valued at $34,000 after buying an additional 1,198 shares during the last quarter. Citigroup Inc. acquired a new stake in Integral Ad Science during the 3rd quarter worth $40,000. Strs Ohio boosted its stake in Integral Ad Science by 33.3% during the 1st quarter. Strs Ohio now owns 5,200 shares of the company’s stock worth $71,000 after purchasing an additional 1,300 shares during the period. Richelieu Gestion PLC purchased a new position in Integral Ad Science during the 1st quarter worth $93,000. Finally, Metropolitan Life Insurance Co NY acquired a new position in Integral Ad Science in the third quarter valued at $108,000.

NASDAQ IAS opened at $10.17 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 3.37 and a current ratio of 3.37. The firm has a market cap of $1.58 billion and a price-to-earnings ratio of -29.91. The firm has a 50 day simple moving average of $11.69 and a 200-day simple moving average of $15.64. Integral Ad Science has a one year low of $9.38 and a one year high of $29.68.

Integral Ad Science (NASDAQ:IASGet Rating) last issued its quarterly earnings results on Wednesday, May 11th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.05. Integral Ad Science had a negative net margin of 14.03% and a negative return on equity of 5.60%. Equities analysts predict that Integral Ad Science will post 0.13 EPS for the current fiscal year.

Integral Ad Science Company Profile (Get Rating)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, Germany, Italy, Spain, Sweden, Singapore, Australia, France, Japan, Canada, India, and Brazil. The company provides IAS Signal, a cloud-based technology platform that offers actionable insights; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Further Reading

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.